default author photo

Imogen Anastasiou

Pion Inc

SCHOLARLY PAPERS

2

DOWNLOADS

150

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Biopharmaceutics of Subcutaneous Oligonucleotides. Part 1: The Effect of Drug Concentration, Injection Volume and Extracellular Matrix Composition on the Release of Oligonucleotides in Vitro

Number of pages: 17 Posted: 21 Aug 2025
Karin Somby, Clara Mankour, Marieta Duvnjak, Thomas Dimke, Paulo G. Santos, Karoline Bechtold-Peters, Imogen Anastasiou, Conor Gomes, Driton Vllasaliu and Ben Forbes
Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG, Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG, Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG, Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG, Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG, Novartis Pharma AG, Pion Inc, Pion Inc, King’s College London and affiliation not provided to SSRN
Downloads 111 (635,507)

Abstract:

Loading...

Subcutaneous injection site simulator (SCISSOR), in vitro release, small interfering ribonucleic acids (siRNA), Antisense Oligonucleotide (ASO), Artificial extracellular matrix (ECM), Collagen, Biopharmaceutics

2.

Hydrogel Formats to Model Potential Drug Interactions Occurring at the Subcutaneous Injection Site

Number of pages: 30 Posted: 12 Feb 2024
Conor Gomes, Kate Gridley, Imogen Anastasiou, Bálint Sinkó and Randall Mrsny
Pion Inc, University of Bath, Pion Inc, Pion Inc and University of Bath
Downloads 39 (1,196,171)
Citation 1

Abstract:

Loading...

subcutaneous injection, Extracellular Matrix, in vitro model, drug fate.